Prosecution Insights
Last updated: July 17, 2026
Application No. 18/288,788

Aromatising Food And Beverages

Final Rejection §102§112
Filed
Oct 27, 2023
Priority
May 04, 2021 — GB 2106330.0 +1 more
Examiner
LI, CHANGQING
Art Unit
1791
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Koninklijke Douwe Egberts B.V.
OA Round
2 (Final)
30%
Grant Probability
At Risk
3-4
OA Rounds
11m
Est. Remaining
62%
With Interview

Examiner Intelligence

Grants only 30% of cases
30%
Career Allowance Rate
91 granted / 307 resolved
-35.4% vs TC avg
Strong +33% interview lift
Without
With
+32.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 8m
Avg Prosecution
70 currently pending
Career history
385
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
91.5%
+51.5% vs TC avg
§102
3.5%
-36.5% vs TC avg
§112
2.0%
-38.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 307 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim status The examiner acknowledged the amendment made to the claims on 04/14/2026. Claims 1-12 and 14-21 are pending in the application. Claims 17-20 are currently amended. Claims 2, 9-12, 18, 21-22 and 27-30 remain cancelled. Claims 1-12, 14-16 and 21 are withdrawn without traverse in response to the restriction requirement. Claims 17-20 are hereby examined on the merits. Examiner Note Any objections and/or rejections that are made in the previous actions and are not repeated below, are hereby withdrawn. Claim Objections Claim 20 is objected to because of the following informalities: “ The protected food or beverage material aroma compounds” should read “Protected food or beverage material aroma compounds”. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claim 19 is rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Claim 19 depends claim 17 and recites that the protected food or beverage aroma compounds comprise aldehydes protected by acetal protecting group. However, given that claim 17 recites that the protected food or beverage material aroma compounds comprise acetal adducts of the aldehydes with one or more of quinic acid, chlorogenic acid, or derivatives thereof, the subject matter that the protected food or beverage aroma compounds comprise aldehydes protected by an acetal protecting group as recited in claim 19 is already encompassed by claim 17. As such, claim 19 fails to further limit the subject matter of claim 17. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 17-20 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Dierbach US Patent Application Publication No. 2016/0192671 A1(hereinafter referred to as Dierbach), and as evidenced by Gigl, “Identification and Quantitation of Reaction Products from Quinic Acid, Quinic Acid Lactone, and Chlorogenic Acid with Strecker Aldehydes in Roasted Coffee”, J. Agric. Food Chem., 2021, 69, 1027−1038 (cited in the IDS filed 10/27/2023, hereinafter referred to as Gigl). Regarding claims 17-20, Dierbach teaches a coffee beverage brewed from medium roast coffee beans and water (0104). As evidenced by Gigl, a coffee beverage prepared from a medium roast coffee contains acetalization products (e.g., acetal adduct) of quinic acid or chlorogenic acid and one or more coffee aroma compounds (e.g., Strecker aldehydes, acetaldehyde, propanal, methylpropanal, 2- and 3-methylbutanal, and methional) (Abstract; Fig. 1; Fig. 1, 3 and 5; page 1034, “ UHPLC−MS/MS Screening of the Aldehyde Adducts (1−18) in Roasted Coffee Beverages; page 1035, left hand column, 2nd para.). Further regarding claim 20, it is noted that the limitation about “separating the one or more food or beverage material aroma compounds from a food or beverage material, protecting the separated one or more food or beverage material aroma compounds with the protecting group, and storing the protected food or beverage material aroma compounds” is a product-by- process limitation."[E]ven though product-by-process claims are limited by and defined by the process, determination of patentability is based on the product itself. The patentability of a product does not depend on its method of production. If the product in the product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process." In re Thorpe, 777 F.2d 695, 698, 227 USPQ 964, 966 (Fed. Cir. 1985). See MPEP 2113. In the instant case, Dierbach as recited above teaches protected food beverage aroma compounds comprising an acetal adduct of aldehydes with protecting groups (e.g., quinic acid or chlorogenic acid). Although Dierbach does not teach that the acetal adduct is produced by separating aldehydes from coffee material followed by protecting (e.g., reacting) the aldehydes with quinic acid or chlorogenic acid and storing the acetal adduct of aldehydes, the final acetal adduct of aldehydes and quinic acid/ chlorogenic acid appear materially indistinguishable form the final product as recited in claim 20, therefore, claim 20 is anticipated by Dierbach. Response to Arguments Applicant’s arguments filed 04/14/2026 with respect to claims 17-20 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHANGQING LI whose telephone number is (571)272-2334. The examiner can normally be reached 9:00-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, NIKKI H DEES can be reached at 571-270-3435. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CHANGQING LI/Primary Examiner, Art Unit 1791
Read full office action

Prosecution Timeline

Oct 27, 2023
Application Filed
Jan 14, 2026
Non-Final Rejection mailed — §102, §112
Apr 14, 2026
Response Filed
May 07, 2026
Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12667126
MALONYL STEVIOL GLYCOSIDES AND THEIR COMESTIBLE USE
3y 5m to grant Granted Jun 30, 2026
Patent 12653217
COMPOSITION FOR ENHANCING UMAMI COMPRISING TYROSINE-AMINO ACID PEPTIDE AND USE THEREOF
2y 10m to grant Granted Jun 16, 2026
Patent 12642285
DIETARY SUPPLEMENT DERIVED FROM THE RUMINAL CONTENT OF BOVINES AND SHEEP AND THE CAECAL CONTENT OF RABBIT
2y 10m to grant Granted Jun 02, 2026
Patent 12635718
FLAVANONE DERIVATIVES AND THEIR USE AS SWEETNESS ENHANCERS
4y 3m to grant Granted May 26, 2026
Patent 12630811
LACTASE ENZYMES WITH IMPROVED PROPERTIES AT ACIDIC PH
5y 1m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
30%
Grant Probability
62%
With Interview (+32.9%)
3y 8m (~11m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 307 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month